SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-23-014049
Filing Date
2023-03-27
Accepted
2023-03-27 17:44:29
Documents
2
Period of Report
2023-03-16

Document Format Files

Seq Description Document Type Size
1 form3.html 3  
1 form3.xml 3 12777
2 EXHIBIT 24.1 brhc10050431_24-1.htm EX-24.1 8553
  Complete submission text file 0001140361-23-014049.txt   22711
Mailing Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005
Business Address 1400 SIERRA POINT PARKWAY BLDG C, SUITE 200 BRISBANE CA 94005 (650)-822-5500
Annexon, Inc. (Issuer) CIK: 0001528115 (see all company filings)

IRS No.: 275414423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ANNEXON, INC. 180 KIMBALL WAY, SUITE 200 SOUTH SAN FRANCISCO CA 94080
Business Address
Yednock Ted (Reporting) CIK: 0001818525 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39402 | Film No.: 23765660